The brain implant company is adding office and manufacturing space in Del Valle facilities and hiring for jobs on software, ...
3don MSN
Musk, Altman and China are fighting to control a potential $320 billion market for brain implants
It’s still very early days for brain chips that let people control devices with their thoughts — but the market opportunity ...
Neuralink has enrolled 21 patients in human trials of its brain-computer interface, ‘The Link,’ enabling users to control devices with their minds.
Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...
The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked on Neuralink.
China’s brain-computer interface (BCI) industry is accelerating beyond the experimental stage, positioning itself as a formidable contender in a field often associated with Elon Musk’s Neuralink.
China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
Neuralink’s current trial, named the The PRIME Study, is aimed at providing individuals with quadriplegia the ability to ...
OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a new competitor to Elon Musk’s Neuralink, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results